| Patents for A61K 41 - Medicinal preparations obtained by treating materials with wave energy or particle radiation (9,445) |
|---|
| 03/17/2000 | CA2282234A1 Antitumor activity strengthening method of crude drugs, composition containing crude drug strengthening antitumor activity, evaluating method of antitumor effectiveness by crude drug treatment, and evaluating method of antitumor effectiveness of crude drug |
| 03/16/2000 | WO1999058570A3 Antibodies to the ed-b domain of fibronectin, conjugates containing them and use therefor for diagnosis and therapy of tumors and diseases associated with angiogenesis |
| 03/15/2000 | EP0985416A2 Process and device for making an extract of biological material |
| 03/14/2000 | US6037357 Antitumor and antimetastasis agents |
| 03/14/2000 | US6037329 Compositions containing nucleic acids and ligands for therapeutic treatment |
| 03/14/2000 | US6036941 Fluorogenic substrates for diagnosis and photodynamic treatment of tumors |
| 03/09/2000 | WO2000012512A1 Porphyrin derivatives, their use in photodynamic therapy and medical devices containing them |
| 03/09/2000 | WO2000012134A1 Electrically treated composition and use thereof |
| 03/09/2000 | WO2000012062A1 Local delivery of medications to the heart |
| 03/09/2000 | WO2000012006A1 Pharmaceutically enhanced low-energy radiosurgery |
| 03/09/2000 | CA2342912A1 Local delivery of medications to the heart |
| 03/08/2000 | EP0983273A1 Ethylene glycol esters of monohydrobenzoporphyrin derivatives as photoactive agents |
| 03/08/2000 | EP0983272A1 A new class of benzoporphyrin derivative photoactive compounds |
| 03/08/2000 | EP0983090A1 Photodynamic and sonodynamic therapy and agents and system for use therefor |
| 03/08/2000 | EP0983060A1 Solid porous matrices and methods of making and using the same |
| 03/08/2000 | EP0861054A4 Photochemistry for the preparation of biologic grafts-allografts and xenografts |
| 03/08/2000 | EP0782388A4 Photodynamic inactivation of viral and bacterial blood contaminants with halogenated coumarin and furocoumarin sensitizers |
| 03/08/2000 | EP0591355B1 Porphycene compounds for photodynamic therapy |
| 03/07/2000 | US6034267 Esters of 5-aminolevulinic acid as photosensitizing agents in photochemotherapy |
| 03/07/2000 | US6034105 Alteration of circadian rhythmicity with a tachykinin antagonist |
| 03/07/2000 | US6033646 Method of preparing fluorinated gas microspheres |
| 03/02/2000 | WO2000010604A1 Gene therapy for regulating smooth muscle cell tone |
| 03/02/2000 | WO2000010576A1 Method of producing means for treating the human body |
| 03/02/2000 | WO2000010575A1 Use of solar radiation in the form of ointment, cream, lotion or solution for treating dermatosis |
| 03/02/2000 | CA2339800A1 Gene therapy for regulating smooth muscle cell tone |
| 03/02/2000 | CA2253058A1 Therapeutic composition that produce and immune response |
| 03/01/2000 | EP0981371A1 Green porphyrins as immunomodulators |
| 03/01/2000 | EP0981333A1 Novel acoustically active drug delivery systems |
| 03/01/2000 | EP0680365B1 Activation of photosensitive agents |
| 03/01/2000 | CN1246054A Use of green porphyrins for manufacture of medicament for treatment of secondary cataracts |
| 02/24/2000 | DE19837790A1 Manufacture of human pharmaceuticals, foodstuffs and cosmetics comprises the use of one or more physiologically compatible gases to enrich and potentiate the activity of the basic ingredients |
| 02/23/2000 | EP0980202A1 Methods for viral inactivation and compositions for use in same |
| 02/22/2000 | US6028066 For delivering higher concentrations of bioactive agents to improve efficacy of the bioactive agents |
| 02/17/2000 | WO2000007630A1 Nucleic acid delivery |
| 02/17/2000 | WO2000007514A1 Treatment of pigmented tissues using optical energy |
| 02/17/2000 | WO2000007508A1 Ultrasound assembly for use with a catheter |
| 02/17/2000 | WO1993014791A3 Method of inactivation of viral and bacterial blood contaminants |
| 02/17/2000 | CA2245202A1 Tumour localising photosensitising compounds |
| 02/16/2000 | EP0979107A1 Light imaging contrast agents |
| 02/16/2000 | EP0979104A1 Sonodynamic therapy using an ultrasound sensitizer compound |
| 02/16/2000 | EP0979103A1 Compounds |
| 02/16/2000 | EP0979071A1 Microparticles useful as ultrasonic contrast agents and for delivery of drugs into the bloodstream |
| 02/15/2000 | US6025477 Atherosclerotic plaque specific antigens, antibodies thereto, and uses thereof |
| 02/15/2000 | US6025365 Chelerythrine and radiation combined tumor therapy |
| 02/15/2000 | US6025351 Method of treating blood which comprises use of diels alder adducts of vinyl porphyrins and metal complexes thereof |
| 02/10/2000 | WO2000006244A2 Loading metal particles into cell membrane vesicles and metal particle use for imaging and therapy |
| 02/10/2000 | WO2000006143A1 Chemically induced intracellular hyperthermia |
| 02/10/2000 | DE19749362A1 Rejuvenation process for middle aged persons prevents destruction of healthy cells using principles of nuclear physics, blocking aging and allowing rejuvenation processes to set in |
| 02/10/2000 | CA2337690A1 Chemically induced intracellular hyperthermia |
| 02/09/2000 | EP0977598A1 Nmr image compounds |
| 02/09/2000 | EP0977594A1 Ultrasound imaging of tissue perfusion by pulse energy disruption of contrast agent |
| 02/09/2000 | EP0977593A1 Embolus therapy using insoluble microparticles or vesicles containing contrast agents |
| 02/09/2000 | EP0977592A1 Method for improved selectivity in photo-activation of molecular agents |
| 02/08/2000 | US6022981 Key intermediates in synthesizing 5,10-disubstituted porphyrin compounds or other 5,10-disubstituted polypyrrolic macrocycles. |
| 02/08/2000 | US6022541 Immunological preparation for concurrent specific binding to spatially exposed regions of vascular permeability factor bound in-vivo to a tumor associated blood vessel |
| 02/03/2000 | WO1999065517A3 Therapeutic compositions that produce an immune response by altering the antigen |
| 02/03/2000 | WO1999058149B1 Controlled activation of targeted radionuclides |
| 02/02/2000 | CN1243445A Photochemotherapeutic compositions |
| 02/01/2000 | US6020308 Methods for improving therapeutic effectiveness of treatment of vascularization disorders |
| 01/27/2000 | WO2000003758A1 Controlled removal of biological membrane by pyrotechnic charge for transmembrane transport |
| 01/25/2000 | US6018678 Collecting analyte to be measured in blood or lymph sample |
| 01/25/2000 | US6018058 1,4 dihydrodioxins and related compounds as DNA cleaving reagents |
| 01/25/2000 | US6017902 Boron containing amino acid compounds and methods for their use |
| 01/25/2000 | US6017691 4'-primary aminopsoralen and platelet compositions |
| 01/20/2000 | WO2000002590A1 Radiation and nanoparticles for enhancement of drug delivery in solid tumors |
| 01/20/2000 | WO2000002588A1 Targeted site specific drug delivery compositions and method of use |
| 01/20/2000 | WO2000002585A1 Retarding tumor angiogenesis related growth |
| 01/20/2000 | WO2000002491A1 Apparatus and method for efficient high energy photodynamic therapy of acne vulgaris and seborrhea |
| 01/19/2000 | EP0971710A1 Use of chelerythrine and radiation for tumor therapy |
| 01/19/2000 | EP0971692A2 Specific magnetosome, method for the production and use thereof |
| 01/13/2000 | WO2000001698A1 Porphyrin derivatives and their use in photodynamic therapy and mri diagnosis |
| 01/13/2000 | WO2000001414A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | WO2000001413A1 Intracellular sensitizers for sonodynamic therapy |
| 01/13/2000 | WO2000001412A1 Method for activating an inactive solution |
| 01/13/2000 | WO2000001411A1 Farnesyl protein transferase inhibitors with in vivo radiosensitizing properties |
| 01/13/2000 | WO2000001350A2 Material for modifying the optical properties of different cells, device for applying such a material, diagnostic apparatus for determining the optical properties of cells and device for irradiating cells |
| 01/13/2000 | WO1999030745A3 Dota-biotin derivatives |
| 01/13/2000 | CA2336134A1 Use of texaphyrins in macrophage-mediated disease |
| 01/13/2000 | CA2335808A1 Intracellular sensitizers for sonodynamic therapy |
| 01/13/2000 | CA2335113A1 Material for modifying the optical properties of different cells, device for applying such a material, diagnostic apparatus for determining the optical properties of cells and device for irradiating cells |
| 01/06/2000 | WO2000000250A1 Synergism of photodynamic and electropermeation effects on cell vitality as a novel cytotoxic agent |
| 01/06/2000 | WO2000000248A1 A device for protection against the sun and application of substance to the skin |
| 01/06/2000 | CA2336306A1 Indium photosensitizers for pdt |
| 01/06/2000 | CA2335888A1 Synergism of photodynamic and electropermeation effects on cell vitality as a novel cytotoxic agent |
| 01/06/2000 | CA2335556A1 A device for protection against the sun and application of substance to the skin |
| 01/05/2000 | EP0968002A1 Concurrent in-vivo immunoconjugate binding to multiple epitopes of vascular permeability factor on tumor-associated blood vessels |
| 01/05/2000 | EP0967997A1 Pharmaceutical composition for eliminating membrane-mediated cell resistance |
| 01/05/2000 | EP0967912A1 Chemiluminescent sources for photodynamic therapy and photomedicine |
| 01/05/2000 | DE19831217A1 Neue Porphyrinderivate, diese enthaltende pharmazeutische Mittel und ihre Verwendung in der photodynamischen Therapie und MRI-Diagnostik New porphyrin derivatives, pharmaceutical compositions containing them and their use in photodynamic therapy and MRI diagnosis |
| 01/04/2000 | US6010890 Method for viral inactivation and compositions for use in same |
| 01/04/2000 | US6010445 Radioactive medical device and process |
| 01/04/2000 | CA1340870C Heat-generating ceramics body for hyperthermia and method of producing the same |
| 12/29/1999 | WO1999067249A1 Alkyl ether analogs of chlorins having an n-substituted imide ring |
| 12/29/1999 | WO1999066980A1 Sonophoresis method and apparatus |
| 12/29/1999 | WO1999066962A1 Method of inactivating viruses |
| 12/29/1999 | WO1999066959A2 Compositions and methods for delivery of genetic material for altering neuronal growth, regeneration, and survival |
| 12/29/1999 | WO1999066831A2 Utilization of 5-aminolevulinic acid or a derivative thereof for photodynamic diagnosis or photodynamic therapy of diseases of the parodontium and teeth |
| 12/29/1999 | EP0966481A2 Compositions and methods for treating infections using cationic peptides alone or in combination with antibiotics |
| 12/29/1999 | EP0966427A1 Preparation of acid amides and metallisation of compounds |
| 12/29/1999 | CA2336217A1 Method of inactivating viruses |